Bharti R Vaidya1, Ritu Chauhan2, Abhishek Chauhan2 and Sachin C Narwadiya1
1School of Public Health, Poornima University, Jaipur, Rajasthan, India
2Amity University, Sector-125, Noida, Uttar Pradesh, India
*Corresponding author:snarwadiya@gmail.com
Abstract
In the recent corona pandemic, the existing diseases among the Public like cardiovascular disease (CVD), diabetes, hypertension, spondylitis, and arthritis have become more severe. The lifestyle changes, way of working, clothing, food habits given more numbers of diabetic patients. During corona pandemics, antibiotics increased to a greater extent in society leading to antimicrobial resistance. Self-medication and unethical use of medicines also increased, leading to other problems in public health. In this review study, the associated disease of the corona pandemic is studied for its impact.
Keywords Cardiovascular disease(CVD), diabetes, hypertension, spondylitis, arthritis, corona pandemic
Copyright
This is an open-access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Ahmed, S., Gasparyan, A. Y., & Zimba, O. (2021). Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatology International, 1-14.
Bhaskar, S., Rastogi, A., Chattu, V. K., Adisesh, A., Thomas, P., Alvarado, N., & Walker, A. H. (2020). Key strategies for clinical management and improvement of healthcare services for cardiovascular disease and diabetes patients in the coronavirus (COVID-19) settings: recommendations from the REPROGRAM consortium. Frontiers in cardiovascular medicine, 7, 112.
Bollipo, S., Kapuria, D., Rabiee, A., Ben-Yakov, G., Lui, R. N., Lee, H. W., & Dhanasekaran, R. (2020). One world, one pandemic, many guidelines: management of liver diseases during COVID-19. Gut, 69(8), 1369-1372.
Cai, J., Zhang, X. J., Ji, Y. X., Zhang, P., She, Z. G., & Li, H. (2020). Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases. Circulation research, 126(5), 679-704.
Choudhary, N., Lahiri, K., & Singh, M. (2021). Increase and consequences of self‐medication in dermatology during COVID‐19 pandemic: An initial observation. Dermatologic Therapy, 34(1).
Drucker, D. J. (2020). Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocrine reviews, 41(3), 457-470.
Ghai, S. (2020). Are dental schools adequately preparing dental students to face outbreaks of infectious diseases such as COVID‐19?
Mukherjee, S., Banerjee, O., Singh, S., & Maji, B. K. (2020). COVID 19 could trigger global diabetes burden–A hypothesis. Diabetes & Metabolic Syndrome, 14(5), 963.
Ranjan, A., Chauhan, A., Gurnani, M., & Jindal, T. (2020). Potential phytochemicals as efficient protease inhibitors of 2019-nCoV.
Sacks, L. J., Pham, C. T., Fleming, N., Neoh, S. L., & Ekinci, E. I. (2020). Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic. diabetes research and clinical practice, 166, 108296.
Wicaksana, A. L., Hertanti, N. S., Ferdiana, A., & Pramono, R. B. (2020). Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1109-1120.
License Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
